93
Views
3
CrossRef citations to date
0
Altmetric
CASE REPORT

Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin

, , , , , & show all
Pages 377-380 | Received 10 Jul 2006, Accepted 21 Jul 2006, Published online: 12 Jul 2009
 

Abstract

Pegylated liposomal doxorubicin (PLD) is usually used in disseminated HIV‐related Kaposi's sarcoma (KS). It is the first‐line treatment or second‐line therapy in patients who do not tolerate or do not respond to polychemotherapy since 1995, when it was approved by the FDA. We report two cases of disseminated classic KS not associated with immunosuppression in which HHV‐8 infection was demonstrated. They showed an excellent response to PLD, with good tolerance and an absence of side effects.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.